The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monkeypox Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Monkeypox Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
This report is a detailed and comprehensive analysis for global Monkeypox Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Monkeypox Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monkeypox Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Monkeypox Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals and Emergent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Monkeypox Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injectable
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Market segment by players, this report covers
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monkeypox Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monkeypox Treatment, with revenue, gross margin and global market share of Monkeypox Treatment from 2018 to 2023.
Chapter 3, the Monkeypox Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Monkeypox Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Monkeypox Treatment.
Chapter 13, to describe Monkeypox Treatment research findings and conclusion.
The global Monkeypox Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
This report is a detailed and comprehensive analysis for global Monkeypox Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Monkeypox Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Monkeypox Treatment market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monkeypox Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Monkeypox Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals and Emergent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Monkeypox Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injectable
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Market segment by players, this report covers
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monkeypox Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monkeypox Treatment, with revenue, gross margin and global market share of Monkeypox Treatment from 2018 to 2023.
Chapter 3, the Monkeypox Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Monkeypox Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Monkeypox Treatment.
Chapter 13, to describe Monkeypox Treatment research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Monkeypox Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monkeypox Treatment by Type
1.3.1 Overview: Global Monkeypox Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Monkeypox Treatment Consumption Value Market Share by Type in 2022
1.3.3 Oral
1.3.4 Injectable
1.4 Global Monkeypox Treatment Market by Application
1.4.1 Overview: Global Monkeypox Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Online Pharmacy
1.4.4 Retail Pharmacy
1.5 Global Monkeypox Treatment Market Size & Forecast
1.6 Global Monkeypox Treatment Market Size and Forecast by Region
1.6.1 Global Monkeypox Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Monkeypox Treatment Market Size by Region, (2018-2029)
1.6.3 North America Monkeypox Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Monkeypox Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Monkeypox Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Monkeypox Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Monkeypox Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Bavarian Nordic
2.1.1 Bavarian Nordic Details
2.1.2 Bavarian Nordic Major Business
2.1.3 Bavarian Nordic Monkeypox Treatment Product and Solutions
2.1.4 Bavarian Nordic Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bavarian Nordic Recent Developments and Future Plans
2.2 Chimerix, Inc.
2.2.1 Chimerix, Inc. Details
2.2.2 Chimerix, Inc. Major Business
2.2.3 Chimerix, Inc. Monkeypox Treatment Product and Solutions
2.2.4 Chimerix, Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Chimerix, Inc. Recent Developments and Future Plans
2.3 CIDIC Company Limited
2.3.1 CIDIC Company Limited Details
2.3.2 CIDIC Company Limited Major Business
2.3.3 CIDIC Company Limited Monkeypox Treatment Product and Solutions
2.3.4 CIDIC Company Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CIDIC Company Limited Recent Developments and Future Plans
2.4 Emcure Pharmaceuticals
2.4.1 Emcure Pharmaceuticals Details
2.4.2 Emcure Pharmaceuticals Major Business
2.4.3 Emcure Pharmaceuticals Monkeypox Treatment Product and Solutions
2.4.4 Emcure Pharmaceuticals Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Emcure Pharmaceuticals Recent Developments and Future Plans
2.5 Emergent
2.5.1 Emergent Details
2.5.2 Emergent Major Business
2.5.3 Emergent Monkeypox Treatment Product and Solutions
2.5.4 Emergent Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Emergent Recent Developments and Future Plans
2.6 Gilead Sciences Inc.
2.6.1 Gilead Sciences Inc. Details
2.6.2 Gilead Sciences Inc. Major Business
2.6.3 Gilead Sciences Inc. Monkeypox Treatment Product and Solutions
2.6.4 Gilead Sciences Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.7 Hetero Drugs Limited
2.7.1 Hetero Drugs Limited Details
2.7.2 Hetero Drugs Limited Major Business
2.7.3 Hetero Drugs Limited Monkeypox Treatment Product and Solutions
2.7.4 Hetero Drugs Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hetero Drugs Limited Recent Developments and Future Plans
2.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
2.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Details
2.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Major Business
2.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product and Solutions
2.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Developments and Future Plans
2.9 Mylan N.V.
2.9.1 Mylan N.V. Details
2.9.2 Mylan N.V. Major Business
2.9.3 Mylan N.V. Monkeypox Treatment Product and Solutions
2.9.4 Mylan N.V. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan N.V. Recent Developments and Future Plans
2.10 Olon S.p.A.
2.10.1 Olon S.p.A. Details
2.10.2 Olon S.p.A. Major Business
2.10.3 Olon S.p.A. Monkeypox Treatment Product and Solutions
2.10.4 Olon S.p.A. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Olon S.p.A. Recent Developments and Future Plans
2.11 Piramal Pharma Solutions
2.11.1 Piramal Pharma Solutions Details
2.11.2 Piramal Pharma Solutions Major Business
2.11.3 Piramal Pharma Solutions Monkeypox Treatment Product and Solutions
2.11.4 Piramal Pharma Solutions Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.12 SIGA Technologies Inc.
2.12.1 SIGA Technologies Inc. Details
2.12.2 SIGA Technologies Inc. Major Business
2.12.3 SIGA Technologies Inc. Monkeypox Treatment Product and Solutions
2.12.4 SIGA Technologies Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 SIGA Technologies Inc. Recent Developments and Future Plans
2.13 Sonofi SA
2.13.1 Sonofi SA Details
2.13.2 Sonofi SA Major Business
2.13.3 Sonofi SA Monkeypox Treatment Product and Solutions
2.13.4 Sonofi SA Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sonofi SA Recent Developments and Future Plans
2.14 Teva Pharmaceutical Industries Limited
2.14.1 Teva Pharmaceutical Industries Limited Details
2.14.2 Teva Pharmaceutical Industries Limited Major Business
2.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Product and Solutions
2.14.4 Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Teva Pharmaceutical Industries Limited Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monkeypox Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Monkeypox Treatment by Company Revenue
3.2.2 Top 3 Monkeypox Treatment Players Market Share in 2022
3.2.3 Top 6 Monkeypox Treatment Players Market Share in 2022
3.3 Monkeypox Treatment Market: Overall Company Footprint Analysis
3.3.1 Monkeypox Treatment Market: Region Footprint
3.3.2 Monkeypox Treatment Market: Company Product Type Footprint
3.3.3 Monkeypox Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Monkeypox Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Monkeypox Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Monkeypox Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Monkeypox Treatment Market Forecast by Application (2024-2029)
6 North America
6.1 North America Monkeypox Treatment Consumption Value by Type (2018-2029)
6.2 North America Monkeypox Treatment Consumption Value by Application (2018-2029)
6.3 North America Monkeypox Treatment Market Size by Country
6.3.1 North America Monkeypox Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Monkeypox Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Monkeypox Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Monkeypox Treatment Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Monkeypox Treatment Consumption Value by Type (2018-2029)
7.2 Europe Monkeypox Treatment Consumption Value by Application (2018-2029)
7.3 Europe Monkeypox Treatment Market Size by Country
7.3.1 Europe Monkeypox Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Monkeypox Treatment Market Size and Forecast (2018-2029)
7.3.3 France Monkeypox Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Monkeypox Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Monkeypox Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Monkeypox Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Monkeypox Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Monkeypox Treatment Market Size by Region
8.3.1 Asia-Pacific Monkeypox Treatment Consumption Value by Region (2018-2029)
8.3.2 China Monkeypox Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Monkeypox Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Monkeypox Treatment Market Size and Forecast (2018-2029)
8.3.5 India Monkeypox Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Monkeypox Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Monkeypox Treatment Market Size and Forecast (2018-2029)
9 South America
9.1 South America Monkeypox Treatment Consumption Value by Type (2018-2029)
9.2 South America Monkeypox Treatment Consumption Value by Application (2018-2029)
9.3 South America Monkeypox Treatment Market Size by Country
9.3.1 South America Monkeypox Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Monkeypox Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Monkeypox Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Monkeypox Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Monkeypox Treatment Market Size by Country
10.3.1 Middle East & Africa Monkeypox Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Monkeypox Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Monkeypox Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Monkeypox Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Monkeypox Treatment Market Drivers
11.2 Monkeypox Treatment Market Restraints
11.3 Monkeypox Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Monkeypox Treatment Industry Chain
12.2 Monkeypox Treatment Upstream Analysis
12.3 Monkeypox Treatment Midstream Analysis
12.4 Monkeypox Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
